Floatz logo

Cyclosporin A

Non-Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Centerprotein_peptidePhase 3Active
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
95/ 100

Competitive context

372 Active assets in the Non-Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
PEGASPARGASE
Ciusss de L'Est de l'Île de Montréal
Phase 4BBB
Adriamycin
National Cancer Institute (NCI)
Phase 4BBB
Prednisolone
Mwanasha Merrill, MD
Phase 3BBB
Entecavir
Fudan University
Phase 4BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 4BBB

View all 50 →

Same molecule, other indications

Cyclosporin A is also rated in:

myelodysplastic/myeloproliferative neoplasmActive
BBB
Indicative · Phase 3
76 / 100
View asset →
disease related to transplantationActive
BBB
Indicative · Phase 4
76 / 100
View asset →
diffuse large B-cell lymphomaActive
BBB
Indicative · Phase 3
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →